Exploring Collaboration with Third Parties and the Impact on Document Management


The trend towards virtual pharma is accelerating and as it does, the life sciences industry is undergoing a profound structural change.

In this RQA article, Ken Hayward, BIOVIA CTO QUMAS will look at how document production, distribution and archiving are affected by the virtual pharma model and, in particular, collaboration in clinical and manufacturing quality settings. It will also highlight our approach to collaboration as we move away from a sponsor to supplier model and towards a many to many collaborative effort supported by both cloud and on-premises systems.

 Please complete the form to access the whitepaper.


BIOVIA White Paper